Successful treatment of Aspergillus peritonitis in a peritoneal dialysis patient.
Aspergillus peritonitis is a rare, potentially fatal complication of continuous ambulatory peritoneal dialysis (CAPD). We report the successful treatment of refractory fungal peritonitis in an 8-year-old girl treated by peritoneal dialysis for 3.3 years. This is the second report of Aspergillus thermomutatus(telemorph: Neosartorya pseudofischeri) in humans. Comprehensive treatment included early removal of the CAPD catheter, the use of liposomal amphotericin B, and the use of itraconazole.
Matsumoto
Naoko
N
Department of Pediatrics, Saiseikai Kurihashi Hospital, 714-6 Kurihashi-cho Kitakatsushika-gun, Saitama 349-1105, Japan. naoko@pine.memail.jp
Shiraga
Hiroshi
H
Takahashi
Kazuhiro
K
Kikuchi
Ken
K
Ito
Katsumi
K
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001228:Aspergillosis / Q000209:etiology*; D002404:Catheterization; D002648:Child; D020878:Device Removal; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000627:therapeutic use; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects* / Q000295:instrumentation; D010538:Peritonitis / Q000382:microbiology*
D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B